Chiron's diversified business model provides multiple revenue streams to balance risk, fund innovation and promote growth. Our strategic focus on cancer and infectious disease supports three product... www.chiron.com/View full profile
Antisoma is a biopharmaceutical company developing novel products for the treatment of cancer. Antisoma's particular focus is the use of monoclonal antibodies to target tumour cells while leaving... www.antisoma.co.uk/View full profile